Novartis reported 10.13B in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Alcon AG ALC:SW 2.08B 201M
Amgen AMGN:US $ 4.33B 1.37B
AstraZeneca AZN:LN 11.54B 4.45B
Bayer BAYN:GR 9.25B 3.88B
Biogen BIIB:US $ 1984.9M 304.4M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Fresenius FRE:GR 8.32B 91M
Fresenius Medical Care FME:GR 3.94B 40.05M
Galapagos GLPG:NA 155.17M 44.65M
Genmab GEN:DC 1.42B 235M
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.49B 123M
Hikma Pharmaceutical HIK:LN 873M 27M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.93B 105M
Merk MRK:US $ 8328M 1460M
Novartis NOVN:VX 10.13B 319M
Novartis NVS:US 10.13B 319M
Orion ORNBV:FH 183.6M 300K
Pfizer PFE:US $ 16447M 3384M
Philips PHIA:NA € 3798M 347M
Recordati REC:IM 262.8M 2.28M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M